logo
  

Leoni AG Q1 Sales Up; Lifts FY21 Sales Outlook

LEONI AG (LEOGN) reported first-quarter consolidated net result of EUR 28 million compared to a loss of EUR 67 million last year. On a per share basis, earnings totaled EUR 0.85 compared to a loss of EUR 2.05 incurred a year ago.

Consolidated sales for the quarter rose to EUR 1.35 billion from EUR 1.13 billion generated in the prior year period.

Aldo Kamper, CEO of Leoni AG, said, "We continued our operational recovery of the preceding quarters in the first quarter of 2021. We reached initial milestones in the improvement of our portfolio with the sale of LEONI Schweiz AG as well as the agreement on the disposal of business units of LEONI Kerpen GmbH."

Looking ahead, despite the persisting Covid-19 pandemic and bottlenecks in the company's global supply chain, the company now expects group sales for fiscal 2021 to increase significantly compared to the previously issued low double-digit percentage range.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The 737 MAX 10, Boeing Co.'s largest 737 Max model, is taking its maiden flight today, reports said citing people familiar with the matter. The flight after months of testing and certification will be around 10 a.m. local time from the Seattle area. The schedule could change depending on weather or other factors. Meanwhile, the jetliner is expected to enter commercial service in 2023. Medical devices supplier Smiths Medical, affiliated to Smiths Group plc, is recalling certain Jelco Hypodermic Needle-Pro Fixed Needle insulin syringes with skewed graduation markings, the U.S. Food and Drug Administration said. The recall was initiated after the company became aware of specific models and lots of Jelco insulin syringes that may exhibit skewed odd number line graduation markings. Saliva-based COVID-19 testing is rolled out as a pilot for public schools in New York City. The new two-month pilot program is being implemented in about 50 New York City public schools and utilizes Fluidigm Technology to offer RT-PCR COVID-19 testing. New York City public schools have instituted mandatory random weekly testing in all reopened school buildings to ensure safer in-person learning.
RELATED NEWS
Follow RTT